FTLF

Image source: The Motley Fool. Thursday, Aug. 13, 2026 at 4:30 p.m. ET Chief Executive Officer - Dayton Judd President - Ryan Hansen Chief Financial Officer - Jakob York Operator: It is now my pleasure to turn the floor over to your host, Dayton Judd, CEO of FitLife Brands. Sir, please go ahead. Dayton Judd: Good afternoon. I'd like to welcome everyone to FitLife's Q2 2026 earnings call. We appreciate you taking the time to join us this afternoon. Joining me on the call is FitLife's President, Ryan Hansen, and FitLife's CFO, Jakob York. For the Q2 of 2026, total revenue was $26.5 million, an increase of 65% compared to the same quarter last year, with the increase driven primarily by the acquisition of Irwin, partially offset by lower revenue for Legacy FitLife. Wholesale revenue was $14.6 million or 55% of revenue, an increase of 156% compared to the Q2 of 2025. Online revenue was $11.9 million or 45% of total revenue, an increase of 14% compared to the Q2 of 2025. Gross margin was 37.0% compared to 42.8% during the Q2 of 2025. The decline in gross margin is primarily due to the acquisition of Irwin, which has historically operated at a lower gross margin than Legacy FitLife. Contribution, which we define as gross profit less advertising and marketing expense, increased 46%, driven primarily by the addition of Irwin, partially offset by lower contribution from Legacy FitLife. Net income for the Q2 of 2026 was $2.0 million, compared to $1.7 million during the Q2 of 2025. Adjusted EBITDA was $3.7 million, a 10% increase compared to the Q2 of 2025. In addition to the year-over-year numbers, I would like to highlight some sequential comparisons. Total revenue increased 4.8% sequentially compared to the Q1 of 2026, with wholesale revenue increasing 3.7% and online revenue increasing 6.3%. Diluted earnings per share has increased sequentially in each of the past three quarters. Although we have been working through a number of challenges in the business over the past three quarters, we are pleased with the progress the team is making. With regard to brand-level performance, I'll start with Legacy FitLife. Total Legacy FitLife revenue for the Q2 of 2026 was $12.4 million, of which 68% was from online sales and 32% was from wholesale customers. This represents a 31% year-over-year decrease in wholesale revenue and a 19% year-over-year decrease in online revenue, or a 23% decrease in total revenue. The online revenue decline was primarily attributable to MRC, and the wholesale revenue decline was primarily attributable to reduced sales to GNC. Sequentially, total revenue for Legacy FitLife for the Q2 of 2026 declined less than a 0.5% Compared to the Q1 of 2026, with wholesale revenue increasing 3.0% and online revenue declining 2.0%. Although the year-over-year declines are still high, we were happy to see the sequential stability during the quarter. Gross margin for Legacy FitLife declined from 42.8% in the Q2 of 2025 to 41.7% in the Q2 of 2026. However, gross margin for Legacy FitLife increased sequentially from 41.2% in the Q1 of 2026 to 41.7% in the Q2 of 2026. In fact, the Q2 of 2026 represents the Q3 in a row that gross margin for Legacy FitLife has increased sequentially, so we are encouraged by that trend. Contribution for Legacy FitLife in the Q2 of 2026 declined 25.9% to $4.2 million, and contribution as a percentage of revenue decreased to 34.1%, compared to 35.4% in the same quarter of 2025. Sequentially, contribution and contribution as a percentage of revenue were approximately flat from the Q1 of 2026 to the Q2 of 2026. Moving on now to Irwin. Total Irwin revenue for the Q2 was $14.1 million, of which $10.7 million or 76% came from wholesale customers and 24% came from online sales. Gross margin for Irwin for the Q2 was 32.8%, and contribution as a percentage of revenue was 29.2%. As previously mentioned, we began selling Irwin products on Amazon in mid-October, and the business has scaled nicely for the past several months. Monthly revenue for Irwin on Amazon reached approximately $0.5 million in December of 2025, approximately $0.8 million in March of 2026, and just under $1 million in June of 2026. Although June revenue was helped by Prime Day, which took place June 23rd through the 26th. Sales for Irwin on Amazon have remained strong since the end of the Q2, with July revenue comparable to June, but without the benefit of Prime Day. In early April, on our Q4 earnings call, I outlined five initiatives we were focused on to drive improved performance in our business. I thought it would be productive to provide a brief update on our progress against each of those. The first initiative was to significantly improve Irwin's supply chain. This is a project that will take several more months before we can declare victory, but I'm pleased with the tangible progress we have made. More specifically, the biggest opportunity was to transition as many of our products as possible to three-year dating compared to the two-year dating the products had at the time of the acquisition. As a reminder, Irwin has historically written off and disposed of approximately $2 million worth of inventory each year, largely because of a combination of high MOQs and a short 12-month selling window, since retail partners require 12 months of shelf life on incoming products. Increasing the shelf life to three years doubles the selling period, resulting in lower inventory obsolescence. As of today, we have approved three-year formulas for 85% of Irwin's products. We have inventory on hand with three-year dating for 12% of Irwin's products, with POs outstanding for an additional 22%. We will continue to transition more and more of our formulas to three years as we reach reorder points. Another supply chain improvement opportunity is to reduce the number of out-of-stock situations. While we don't have this fully behind us yet, I am pleased that lost revenue due to out of stocks declined over 50% in the Q2 of 2026 compared to the Q1 of 2026. Additionally, we are working on other supply chain initiatives around better managing logistics expense, which we expect to favorably impact cost of goods sold. Bottom line, we are making progress improving Irwin's supply chain, which we expect to translate into improved margins in the coming quarters. The second initiative was to improve new product development at Irwin. New product launches are important to maintaining relevance in the nutritional supplement industry. When we bought Irwin, the new product pipeline was almost non-existent. A related problem was that Irwin has historically focused on the nutritional supplement categories where it was the strongest. Unfortunately, its two strongest categories, weight loss and men's health, are declining significantly. In other words, Irwin was previously focused primarily on defending share in declining categories rather than strengthening its presence in growing categories. We have three new products currently in production and slated for launch late during the Q3 or early in the Q4, although unfortunately, most of those are in men's health or weight loss. For future product launches, however, we have a robust pipeline of products in development that are more focused on attractive and growing nutritional supplement categories. Our goal is to launch at least four of these new products each quarter, beginning in 2027. The third initiative was to drive off-Amazon awareness for our products, which we expect to translate into strength on Amazon as well. This strategic shift is in response to the Amazon algorithm changes that we have previously highlighted. During the Q2, we increased our advertising and marketing expense by 16.4% sequentially compared to the Q1 of 2026. Importantly, off Amazon spend is a much higher percentage of that number than it has ever been. Like many of our other initiatives, it is going to take some time before we know the outcome, but we are beginning to see some recent encouraging metrics. For example, average weekly sessions on Amazon for our portfolio of brands, including Dr. Tobias, is higher in the last five weeks compared to the 13-week period prior to Prime Day at the end of June. The fourth initiative was to leverage Irwin's sales team to cross-sell other FitLife products into the wholesale channel. The sales process in wholesale is long, with many retailers resetting planograms only once or potentially twice a year. We previously announced the two MusclePharm SKUs that were added to over 700 Kroger locations late during the Q2. We also previously announced the placement of six MusclePharm SKUs in a regional grocery chain, which was supposed to happen in the Q2 but has been delayed until later this year. We continue to have productive discussions with a number of retailers and hope to have other updates on this initiative in the coming quarters. The fifth initiative was to operate more efficiently with regard to SG&A. SG&A for the Q2 of 2026 was approximately $4.8 million, down 3.8% sequentially from approximately $5.0 million in the Q1 of 2026. On an annualized basis, this improvement is equivalent to approximately $0.8 million. In addition, since the end of the Q2, we have acted on other SG&A reductions and have identified other improvement opportunities we intend to implement over the remainder of this year. As previously indicated, we don't believe any individual SG&A reduction opportunity will be material on its own, but in total, we expect them to be compelling. Now, let me provide a few additional high-level comments and then we can move into Q&A. We have previously fielded questions and provided commentary about subscriber counts on Amazon, particularly when subscriber counts started declining after Amazon made one-time purchase the default buying option about a year ago, rather than Subscribe & Save. Following this change, our subscriber counts declined for several months, with our weakness on Amazon over the past several months probably contributing to the decline. Our total subscriber count on Amazon across all brands bottomed in mid-April, a little above 90,000 subscribers before starting to grow again, and it has increased almost every week since then. Currently, we have approximately 94,000 active subscribers on Amazon across all of our brands. Regarding the balance sheet, we made a scheduled amortization payment of approximately $1.5 million during the Q2, bringing our term loan balance to $36.1 million. We also paid down an additional $2.2 million on our revolving line of credit during the Q2, bringing the balance to $2.0 million. Since closing the Irwin Naturals acquisition through the end of the Q2 of 2026, we have paid off approximately $8.6 million of indebtedness, in addition to paying approximately $2.0 million of transaction-related expenses. At the company's current 6.5% weighted average interest rate, this $8.6 million debt reduction over a period of roughly three quarters saves us approximately $0.6 million in annual interest expense. We intend to continue to deploy excess free cash flow to further reduce indebtedness. On a full year basis, we expect the interest savings to be even greater. To conclude, we've been dealing with a number of challenges over the past three quarters. Some of these challenges, such as general consumer weakness and changes in the Amazon algorithms, are out of our control, and we have to figure out how to adapt. Other challenges, such as supply chain difficulties and new product development, are largely within our control. And although these challenges persist, we believe we are focused on the right priorities, and we are encouraged by the sequential improvements in revenue and profitability during the Q2. That concludes my opening commentary, and we can go ahead and open it up for questions. Operator: Thank you. At this time, we will be conducting a question-and-answer session. If you wish to ask a question, please press star one on your phone at this time. We ask that while posing your question, you please pick up your handset if listening on speakerphone to provide optimum sound quality. Once again, please press star one on your phone at this time if you wish to ask a question, and please hold while we poll for questions. The first question today is coming from Sean McGowan from ROTH Capital Partners. Sean, your line is live. Sean McGowan: Thank you. Hi, Dayton. Hi, Ryan. My first question is about the priority you have placed on growing the share of Irwin's sales online relative to wholesale. Has that met your expectations so far? I would imagine that you have further to go, but so far, has that met your expectations? Related to that, has it eaten into Irwin's wholesale sales, or has it been largely incremental? Dayton Judd: Yeah. Hey, Sean. Thanks for the questions. In terms of expectations, I think it has exceeded our expectations. I think early in the process, shortly after the acquisition, I cannot remember the number off the top of my head, but you all may remember that we sold products wholesale to a third-party that was kind of like the exclusive seller on Amazon. That was in kind of in the range of $2 million-$3 million a year. If you looked at the total dollars paid for those products, it was quite a bit lower than what we are getting right now, right? An easy expectation would have been for us just to take over what they were selling. In a matter of a few months, we not only did that, but we have grown it significantly. There is a number of products that have a lot of momentum and continue to grow. We have one product in particular that we are having a hard time keeping in stock, and it is just one product on its own out of 250, 300 that we sell on Amazon under the Irwin brands that is probably $1.5 million-$2 million a year pacing right now. So we are pleased, right, with the results, and it certainly exceeded our expectations. As far as your second question, it is really hard to determine how much that has cannibalized wholesale, although I think it would be indefensible to argue that it has not at all, that it is entirely incremental. Certainly, some of those sales that we are getting on Amazon are people that used to buy the products in the store. Unfortunately, we cannot quantify it. We're obviously very happy to trade a wholesale unit for a retail unit, right? Sean McGowan: Yeah. Dayton Judd: It's higher revenue for us. It's higher gross profit for us. It's a trade we're happy to make. That said, we wouldn't be where we are without our wholesale partners. We want to grow with them. We're not looking to take volumes out of the wholesale channels and move them to online. We want it to be incremental. Sean McGowan: Thank you. Follow-up then on GNC, this has been a subject for every conference call it seems like, but relative to your expectations, how is that situation evolving? Dayton Judd: Yeah. That one I would say is lower than our expectations. I'm probably not It would not be appropriate for me to comment on someone else's business, but suffice it to say, specialty retail is quite challenged in the U.S. right now. There is significant store closures that are happening. For the stores that remain open, there's significant drops in comps, comp store sales, traffic, however you want to look at it. As we try and get a sense for what those numbers are, we think our declines are in excess of that right now. Another thing to remember though, if you go back and look historically, Q1 and Q2 of 2025 was very strong for the Legacy FitLife wholesale channel, in particular, GNC. You may recall we had a dispute with them- Sean McGowan: Yeah Dayton Judd: late 2024 that resulted in us stopping shipments to them in Q1, in particular, and it probably bled a little bit into Q2. They were restocking their DCs. It's a little bit of a- Sean McGowan: Right Dayton Judd: of a not apples-to-apples comp. But that said, if I look at my business, the things I worry the most about are, number one, declining sales with some of those retail partners where we really can't do much about it. There's nothing I can do that's going to reverse course for a GNC or any of our other retail partners that are struggling. So that's one thing- Sean McGowan: Right Dayton Judd: where in some ways we're along for the ride. The second is, and we've talked about this quite a bit, is MRC, where we have been struggling for about a year and a half, and we think we are, I don't want to say we've inflected or we're nearing an inflection point, but we're certainly seeing some positive indications. So both of those now roll up into Legacy FitLife. GNC, for the most part, explains the declines on the wholesale side, and MRC, for the most part, explains the declines on the online side. The rest of the business, I'm quite content with how things are going. Sean McGowan: Thank you. I'll pass it on. Thank you. Dayton Judd: Yep. Operator: Thank you. Once again, it will be star one on your phone at this time if you wish to ask your question. That is star one if there were any other questions at this time. We did have another question coming from Sean from ROTH Capital Partners. Sean, your line is live. Sean McGowan: Thanks. I am back. This might be the first call you have had in a while where you have not mentioned MusclePharm in any kind of detail. So what are you seeing on that line? Dayton Judd: Yeah. Happy to talk about that. Look, I am happy about MusclePharm right now. Revenue, I would say, is down a bit year-over-year, but up significantly Q1-Q2. We have talked about the challenges with protein pricing in the past. If you look at the numbers we historically reported for MusclePharm, of course, it now rolls into Legacy FitLife. But we started discounting significantly in the Q3 of last year, and investing in advertising to try and grow the brand. We got a lot of uptake with very margin sensitive, primarily international protein companies or people that wanted to take the protein internationally. Then when protein prices went up and we tried raising our prices, all of a sudden they went away. So the bulk of the decline for MusclePharm revenue has been there in those types of customers. If you take those out, the business is actually growing very nicely. The other benefit is margins are up significantly. Like Q2, for example, relative to Q3, Q4, Q1, your margins are several hundred basis points higher for MusclePharm. as we've moved away from the very price sensitive, large, international customers. We launched the two new SKUs in Kroger stores, as well as a number of their other banners. Those didn't hit the shelves until late during the Q2, but for the first several weeks, every week was an uptick. We're continuing to see decent growth there, and we're pleased with where we are and have some additional marketing initiatives to try and continue to drive volume there. All things considered, pretty happy. I'll also add MusclePharm on Amazon, it may be right now our best performing Amazon account. Dr. Tobias is struggling and declining double-digits, MusclePharm right now is growing double-digits. It was growing in 2025, kind of flipped negative like a lot of our accounts did late 2025, early 2026, and was probably down a bit even for Q2 overall. But late in Q2 and then in July and thus far in August, we're seeing some very nice double-digit growth. All things considered, the numbers might look bad on a headline basis or on a revenue basis because we're walking away from less profitable volume. But in terms of profitability margins and all the other accounts, we're seeing everything going in the right direction. Sean McGowan: Which is consistent with what you've said. Thank you very much for addressing that. Thank you. Dayton Judd: Yeah, no problem. Operator: Thank you. Once again, if there were any other questions at this time, please press star one. There were no other questions from the lines at this time. I will now hand the call back to Dayton Judd for closing remarks. Dayton Judd: All right. Thank you all for your participation in the call. If any of you have additional questions, feel free to reach out to me or to our [email protected] email. We look forward to talking to you on our next earnings call in November. Thank you. Operator: Thank you. This concludes today's conference. You may disconnect at this time, and have a wonderful day. Thank you for your participation. Before you buy stock in FitLife Brands, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and FitLife Brands wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $432,621!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,335,314!* Now, it’s worth noting Stock Advisor’s total average return is 976% — a market-crushing outperformance compared to 214% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors. See the 10 stocks » *Stock Advisor returns as of August 20, 2026. This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading the company's SEC filings. Please see our Terms and Conditions for additional details, including our Obligatory Capitalized Disclaimers of Liability. The Motley Fool has positions in and recommends FitLife Brands. The Motley Fool has a disclosure policy. FitLife Brands (FTLF) Q2 2026 Earnings Call Transcript was originally published by The Motley Fool

This article first appeared on GuruFocus. Total Revenue: $26.5 million, up 65% year-over-year, driven primarily by the Irwin acquisition. Wholesale Revenue: $14.6 million (55% of revenue), up 156% year-over-year. Online Revenue: $11.9 million (45% of revenue), up 14% year-over-year. Gross Margin: 37.0%, down from 42.8% in Q2 2025, due to the lower-margin Irwin acquisition. Net Income: $2.0 million, up from $1.7 million in Q2 2025. Adjusted EBITDA: $3.7 million, a 10% increase year-over-year. Legacy FitLife Revenue: $12.4 million, down 23% year-over-year (wholesale down 31%, online down 19%). Legacy FitLife Gross Margin: 41.7%, down from 42.8% in Q2 2025 but up sequentially from 41.2% in Q1 2026. Legacy FitLife Contribution: $4.2 million, down 25.9% year-over-year; contribution margin 34.1%. Irwin Revenue: $14.1 million, with 76% from wholesale and 24% from online. Irwin Gross Margin: 32.8%. Irwin Contribution Margin: 29.2% of revenue. SG&A Expense: Approximately $4.8 million, down 3.8% sequentially from Q1 2026. Debt Reduction: Paid $1.5 million amortization and $2.2 million on revolving credit line; total debt reduction of $8.6 million since Irwin acquisition. Amazon Subscribers: Approximately 94,000 active subscribers, up from a mid-April low of just above 90,000. Warning! GuruFocus has detected 6 Warning Signs with FTLF. Is FTLF fairly valued? Test your thesis with our free DCF calculator. Release Date: August 13, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Total revenue increased 65% year-over-year to $26.5 million, driven by the Irwin acquisition. Online revenue grew 14% year-over-year, with Irwin's Amazon sales scaling to nearly $1 million monthly by June 2026. Adjusted EBITDA rose 10% year-over-year to $3.7 million, and diluted EPS increased sequentially for three consecutive quarters. Legacy FitLife revenue stabilized sequentially, with gross margin improving for the third straight quarter. Debt reduction efforts saved approximately $0.6 million in annual interest expense, with further reductions planned. Legacy FitLife revenue declined 23% year-over-year, with wholesale down 31% and online down 19%. Gross margin fell to 37.0% from 42.8% year-over-year, primarily due to Irwin's lower margins. Irwin's new product pipeline remains weak, with most upcoming launches in declining categories like weight loss and men's health. GNC sales continue to decline, exacerbated by broader specialty retail challenges and store closures. Out-of-stock issues persist, though lost revenue from them decreased by over 50% sequentially. Q: Has the growth of Irwin's online sales met your expectations, and has it cannibalized wholesale sales?A: Dayton Judd, CEO, stated that online growth has exceeded expectations, significantly surpassing the previous third-party Amazon sales of $2-3 million annually. While some cannibalization of wholesale is likely, the trade is favorable due to higher revenue and gross profit per unit. The company aims for incremental growth without taking volume away from wholesale partners. Q: How is the situation with GNC evolving relative to your expectations?A: CEO Dayton Judd noted that performance is below expectations, largely due to significant challenges in specialty retail, including store closures and declining comps. He highlighted that Q1 and Q2 of 2025 were strong due to restocking after a dispute, making comparisons difficult. GNC is the primary driver of wholesale declines, while MRC drives online declines, but the rest of the business is performing well. Q: What are you seeing in the MusclePharm line, which wasn't mentioned in detail this call?A: CEO Dayton Judd reported that revenue is down year-over-year but up significantly sequentially. The decline is attributed to moving away from price-sensitive international protein customers after raising prices. Excluding those customers, the business is growing nicely with margins up several hundred basis points. New Kroger SKUs are showing early promise, and MusclePharm is currently the best-performing Amazon account, growing double digits. Q: What is the progress on improving Irwin's supply chain?A: CEO Dayton Judd detailed progress on transitioning products to three-year dating to reduce inventory obsolescence. 85% of formulas are approved, with 12% of inventory on hand and POs for an additional 22%. Lost revenue due to out-of-stocks declined over 50% sequentially in Q2. These improvements are expected to translate into improved margins in coming quarters. Q: What is the status of new product development at Irwin?A: CEO Dayton Judd stated that three new products are in production for launch in late Q3 or early Q4, though mostly in declining categories like men's health and weight loss. A robust pipeline is focused on growing categories, with a goal to launch at least four new products per quarter starting in 2027. Q: How is the initiative to drive off-Amazon awareness progressing?A: CEO Dayton Judd noted a 16.4% sequential increase in advertising and marketing expense in Q2, with a higher percentage allocated to off-Amazon spend. Early encouraging metrics include higher average weekly sessions on Amazon over the last five weeks compared to the pre-Prime Day period. Q: What is the progress on cross-selling FitLife products through Irwin's wholesale sales team?A: CEO Dayton Judd mentioned the addition of two MusclePharm SKUs to over 700 Kroger locations in late Q2. A placement of six MusclePharm SKUs in a regional grocery chain was delayed until later this year. Discussions with other retailers are ongoing. Q: What is the status of SG&A reduction efforts?A: CEO Dayton Judd reported SG&A of approximately $4.8 million in Q2, down 3.8% sequentially, equivalent to $0.8 million annualized. Additional reductions have been implemented since the end of Q2, with more opportunities identified for the remainder of the year. Q: What is the current status of Amazon subscriber counts?A: CEO Dayton Judd stated that total subscriber counts bottomed in mid-April at just above 90,000 and have increased almost every week since. The company currently has approximately 94,000 active subscribers across all brands. Q: How is the company managing its balance sheet and debt reduction?A: CEO Dayton Judd noted a scheduled amortization payment of $1.5 million and an additional $2.2 million paydown on the revolving line of credit in Q2. Since the Irwin acquisition, the company has paid off approximately $8.6 million of indebtedness, saving about $0.6 million in annual interest expense at the current 6.5% weighted average interest rate. For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. Total revenue growth of 65% was primarily driven by the Irwin acquisition, though this was partially offset by a 23% decline in Legacy FitLife revenue due to weakness at GNC and MRC. Management highlighted sequential stability as a key indicator of recovery, noting that total revenue increased 4.8% and diluted EPS grew for the third consecutive quarter. The decline in consolidated gross margin to 37.0% is attributed to the structural inclusion of Irwin, which historically operates at lower margins than the legacy portfolio. Irwin's Amazon integration has exceeded expectations, with monthly revenue scaling from $0.5 million in December 2025 to nearly $1 million in June 2026. Legacy FitLife wholesale declines were largely driven by reduced sales to GNC, reflecting broader challenges in U.S. specialty retail including store closures and lower foot traffic. MusclePharm is undergoing a strategic pivot, walking away from low-margin international protein volume to focus on more profitable domestic growth and new placements in Kroger. A strategic shift in advertising spend toward off-Amazon channels is being implemented to counter recent changes in Amazon's search and purchase algorithms. Supply chain optimization for Irwin focuses on transitioning 85% of products to three-year dating to reduce the approximately $2 million in annual inventory obsolescence. Management aims to launch at least four new products per quarter starting in 2027, shifting focus from declining categories like weight loss to higher-growth supplement segments. The company intends to continue deploying excess free cash flow toward debt reduction, following the $8.6 million in total indebtedness paid off since the Irwin acquisition. Ongoing SG&A reduction initiatives are expected to yield a compelling total impact, building on the $0.8 million in annualized savings identified during the second quarter. Future performance assumes a continued recovery in Amazon subscriber counts, which bottomed at 90,000 in April and have since grown to approximately 94,000. Out-of-stock situations remain a headwind, though lost revenue from these occurrences declined by over 50% sequentially between Q1 and Q2 2026. Amazon's shift to making 'one-time purchase' the default over 'Subscribe & Save' created a multi-month drag on subscriber counts that only recently began to reverse. A planned placement of six MusclePharm SKUs in a regional grocery chain originally slated for Q2 has been delayed until later in the year. The company faces macro headwinds from general consumer weakness and the ongoing contraction of the specialty retail channel. One stock. Nvidia-level potential. 30M+ investors trust Moby to find it first. Get the pick. Tap here. Management stated that online growth has exceeded expectations, significantly outperforming the previous third-party exclusive seller arrangement. While some cannibalization of wholesale is likely, management views the trade as favorable due to the higher revenue and gross profit per unit in the online channel. Performance at GNC is lower than expectations, driven by systemic challenges in specialty retail including store closures and declining comp store sales. Management noted that year-over-year comparisons are skewed by a 2025 restocking period following a prior dispute, making current declines appear more pronounced. MusclePharm is seeing double-digit growth on Amazon and improved margins after intentionally reducing sales to price-sensitive international customers. New retail placements at Kroger are showing weekly volume upticks, supporting the strategy of focusing on profitable domestic wholesale accounts.

Interested in FitLife Brands Inc.? Here are five stocks we like better. Second-quarter revenue rose 65% year over year to $26.5 million, driven by the Irwin Naturals acquisition, while net income reached $2.0 million and adjusted EBITDA increased 10% to $3.7 million. Irwin generated $14.1 million in revenue, but its lower margin reduced consolidated gross margin to 37.0% from 42.8%. Direct Amazon sales have grown to nearly $1 million monthly, exceeding the company’s expectations. FitLife reduced debt by approximately $3.7 million during the quarter and $8.6 million since acquiring Irwin, lowering annual interest expense by about $600,000; meanwhile, the legacy business remained pressured by declining GNC and online sales. FitLife Brands (NASDAQ:FTLF) reported second-quarter 2026 revenue of $26.5 million, up 65% from a year earlier, as the company’s acquisition of Irwin Naturals more than offset declines in its Legacy FitLife business. Net income rose to $2.0 million from $1.7 million in the prior-year quarter, while adjusted EBITDA increased 10% to $3.7 million. CEO Dayton Judd said revenue also improved sequentially, rising 4.8% from the first quarter. Wholesale revenue increased 3.7% sequentially and online revenue rose 6.3%. Diluted earnings per share has increased in each of the past three quarters, Judd said. → AST SpaceMobile Earnings Just Reminded Investors How Risky Space Can Be “Although we have been working through a number of challenges in the business over the past three quarters, we are pleased with the progress the team is making,” Judd said. Wholesale revenue totaled $14.6 million, representing 55% of total revenue and rising 156% year over year. Online revenue was $11.9 million, or 45% of total revenue, up 14% from the prior-year period. → Nebius’ Q2 Beat Shows the AI Bottleneck Is Capacity, Not Demand Gross margin declined to 37.0% from 42.8% a year earlier, primarily because Irwin has historically operated with a lower gross margin than Legacy FitLife. Contribution, defined by the company as gross profit less advertising and marketing expense, increased 46%, driven mainly by Irwin’s addition. Irwin generated $14.1 million in second-quarter revenue, with $10.7 million, or 76%, coming from wholesale customers. Online sales accounted for the remaining 24%. The business reported a 32.8% gross margin and contribution equal to 29.2% of revenue. → On Holding's Price Stumble May Be an Opening for a Company Built to Run FitLife began selling Irwin products directly on Amazon in mid-October. Monthly Amazon revenue for Irwin reached about $500,000 in December 2025, approximately $800,000 in March 2026 and just under $1 million in June. June results benefited from Prime Day, but Judd said July revenue was comparable to June without that event. During the question-and-answer session, Judd said Irwin’s online sales progress had exceeded management’s expectations. He said FitLife previously sold Irwin products wholesale to a third party that served as an Amazon seller, producing roughly $2 million to $3 million annually in sales. The company has surpassed that level after taking over the channel, he said. Judd acknowledged that some Amazon sales may have displaced wholesale volume, but said FitLife considers the shift favorable because direct retail sales generate higher revenue and gross profit. He added that the company does not intend to take volume from wholesale partners and instead wants online growth to be incremental. Legacy FitLife revenue fell 23% year over year to $12.4 million. Online sales made up 68% of that total and wholesale represented 32%. Wholesale revenue in the legacy business declined 31% from a year earlier, largely due to lower sales to GNC, while online revenue declined 19%, primarily attributable to MRC. However, total Legacy FitLife revenue was down less than 0.5% sequentially, as a 3% increase in wholesale revenue was mostly offset by a 2% decline in online revenue. Legacy FitLife gross margin was 41.7%, down from 42.8% a year ago but up from 41.2% in the first quarter. Judd said the second quarter marked the third consecutive quarter of sequential gross-margin improvement for the legacy operation. Contribution for Legacy FitLife declined 25.9% to $4.2 million, while contribution as a percentage of revenue fell to 34.1% from 35.4% a year ago. On a sequential basis, contribution and contribution margin were approximately flat. Judd said the GNC situation was running below FitLife’s expectations and described specialty retail in the United States as challenged, with store closures and lower comparable-store sales. He also noted that the comparison with the first half of 2025 was affected by GNC restocking distribution centers following a prior shipment dispute. FitLife is working to improve Irwin’s supply chain, including extending product shelf life from two years to three years. Judd said Irwin historically wrote off and disposed of approximately $2 million of inventory annually, partly because retail partners require products to have at least 12 months of remaining shelf life when received. The company has approved three-year formulas for 85% of Irwin products. It currently has inventory carrying three-year dating for 12% of products and purchase orders outstanding for an additional 22%, Judd said. Lost revenue from out-of-stock products declined by more than 50% in the second quarter compared with the first quarter. FitLife also has three Irwin products in production for launch late in the third quarter or early in the fourth quarter. While most of those products are in men’s health or weight-loss categories, management said its longer-term pipeline is focused on growing supplement categories. The company aims to begin launching at least four new products per quarter in 2027. Advertising and marketing expense increased 16.4% sequentially in the second quarter, with a greater portion directed to off-Amazon spending. Judd said average weekly Amazon sessions for the company’s portfolio, including Dr. Tobias, were higher during the five weeks following Prime Day than in the preceding 13-week period. FitLife’s total Amazon subscriber count across brands bottomed at slightly above 90,000 in mid-April and has since increased almost every week, reaching approximately 94,000 active subscribers. Judd said MusclePharm revenue was down year over year but increased significantly from the first to the second quarter. The company has moved away from lower-margin, price-sensitive international protein customers, which contributed to the revenue decline but lifted margins by several hundred basis points versus recent quarters. Two MusclePharm products were added to more than 700 Kroger locations late in the second quarter. Judd said sales increased each week during the initial weeks following the placement. He also said MusclePharm’s Amazon business was posting double-digit growth late in the second quarter and into July and August. On the balance sheet, FitLife made a scheduled term-loan payment of approximately $1.5 million during the quarter, reducing the term-loan balance to $36.1 million. It also reduced its revolving credit balance by $2.2 million to $2.0 million. Since completing the Irwin acquisition through the end of the second quarter, FitLife has repaid approximately $8.6 million of debt and paid about $2 million in transaction-related expenses. At the company’s 6.5% weighted average interest rate, Judd said the debt reduction translates to roughly $600,000 in annual interest-expense savings. The company intends to continue using excess free cash flow to reduce indebtedness. FitLife Brands, Inc provides nutritional supplements for health-conscious consumers in the United States and internationally. The company provides weight loss, sports nutrition, and general health products; sports nutrition products; weight loss and sports nutrition products; sports nutrition and general wellness formulations with an emphasis on natural, vegan, and organic ingredients; and male health and weight loss products, as well as other diet, health, and sports nutrition supplements and related products; and value-oriented sports nutrition and weight loss products. This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. The article "FitLife Brands Q2 Earnings Call Highlights" was originally published by MarketBeat. View MarketBeat's top stocks for August 2026.

OMAHA, NE, Aug. 13, 2026 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. (“FitLife” or the “Company”) (NASDAQ: FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the second quarter ended June 30, 2026. Highlights for the second quarter ended June 30, 2026 include: Total revenue was $26.5 million, an increase of 65% compared to the second quarter of 2025, driven by the acquisition of Irwin Naturals. Wholesale revenue was $14.6 million, representing 55% of total revenue and an increase of 156% compared to the second quarter of 2025. Compared to the first quarter of 2026, total revenue increased 4.8% sequentially, with wholesale revenue increasing 3.7% and online revenue increasing 6.3%. Net income for the second quarter of 2026 was $2.0 million compared to $1.7 million during the same period last year, an increase of 12%, driven primarily by the acquisition of Irwin Naturals, partially offset by lower gross profit from Legacy FitLife. Basic earnings per share and diluted earnings per share were $0.21 and $0.20, respectively, compared to $0.19 and $0.18 for the second quarter of 2025. Adjusted EBITDA was $3.7 million, a 10% increase compared to the second quarter of 2025. The Company ended the quarter with $36.1 million outstanding on its term loan and $2.0 million outstanding on its revolving line of credit, and cash of $1.1 million, or total net debt of $37.0 million. For the second quarter ended June 30, 2026, total revenue increased 65% to $26.5 million compared to $16.1 million during the same period last year, primarily due to the acquisition of Irwin Naturals (“Irwin”), partially offset by lower revenue from Legacy FitLife. Wholesale revenue for the quarter ended June 30, 2026 was $14.6 million, a 156% increase from the same period last year. The Company’s recent acquisition of Irwin contributed $10.7 million of wholesale revenue for the quarter ended June 30, 2026, while Legacy FitLife wholesale revenue declined $1.8 million, or 31%, compared to the same period last year.   The decline in Legacy FitLife wholesale revenue is primarily attributable to lower revenue from one of the Company’s large specialty retail partners. Online revenue for the quarter was $11.9 million, a 14% increase compared to the quarter ended June 30, 2025.  Online revenue accounted for 45% and 65% of the Company’s total revenue during the quarters ended June 30, 2026 and 2025, respectively.  The decline in online revenue as a percentage of total revenue is due to the acquisition of Irwin, which had minimal online revenue at the time of the acquisition. Compared to the first quarter of 2026, total revenue for the second quarter of 2026 increased 4.8% sequentially, with wholesale revenue increasing 3.7% and online revenue increasing 6.3%. Gross margin for the quarter ended June 30, 2026 was 37.0% compared to 42.8% during the same period in the prior year.  The acquisition of Irwin, which historically generated a lower gross margin than Legacy FitLife, was the primary driver of the decline. Net income for the second quarter of 2026 was $2.0 million compared to $1.7 million during the quarter ended June 30, 2025.  Basic earnings per share and diluted earnings per share were $0.21 and $0.20, respectively, compared to $0.19 and $0.18 for the second quarter of 2025. Adjusted EBITDA for the quarter ended June 30, 2026 was $3.7 million, an increase of 10% compared to the same period in 2025. The Company ended the quarter with $36.1 million outstanding on its term loan and $2.0 million outstanding on its revolving line of credit, and cash of $1.1 million, or total net debt of $37.0 million. Since completing the acquisition of Irwin on August 8, 2025, through the end of the second quarter of 2026, the Company has paid off approximately $8.6 million of indebtedness in addition to paying approximately $2.0 million of transaction-related expenses. Performance of Acquired Brands One of the primary metrics used by management to evaluate the performance of the Company’s brands is contribution, a non-GAAP financial measure which management defines as gross profit less advertising and marketing expenditures.  Other companies may also report contribution as a performance metric, but their definition or calculation of contribution may differ from the Company’s.  Management believes that contribution, as defined by the Company, is a particularly relevant performance metric since it incorporates the gross profit associated with a specific brand or collection of brands as well as the advertising and marketing expenditures associated with the same brand or brands.  With limited exceptions, other operating expense incurred by the Company is generally not allocable to a specific brand or collection of brands. Management intends to provide this level of disclosure for acquired brands for approximately two years following a transaction, after which the performance of acquired brands will be reported as part of Legacy FitLife results.  Legacy FitLife consists of thirteen brands, including MRC and MusclePharm, and Irwin consists of three brands.  These collections of brands do not meet the definition of operating segments and are not managed as such. For the second quarter of 2026, Legacy FitLife revenue decreased 23% to $12.4 million compared to the same period last year, driven by a 31% decline in wholesale revenue attributable to lower sales to certain retail partners, primarily GNC, and a 19% decline in online revenue, primarily attributable to MRC. Gross margin for Legacy FitLife decreased to 41.7% during the second quarter of 2026 compared to 42.8% during the second quarter of 2025.  Contribution as a percentage of revenue decreased to 34.1% compared to 35.4% during the second quarter of last year. Irwin was acquired on August 8, 2025; no comparable data exists for the quarter ended June 30, 2025. For the second quarter of 2026, Irwin generated total revenue of $14.1 million, an increase of approximately 10% compared to the first quarter of 2026.  Irwin’s wholesale revenue grew 4% sequentially, while online revenue grew 35%, primarily due to continued growth on Amazon. Online revenue during the second quarter of 2026 represents transactions through Irwin’s websites as well as through Amazon and other e-commerce platforms.  The Company began selling Irwin products on Amazon in mid-October 2025, and sales have continued to increase since launch to an annual run rate of approximately $11 million of revenue by the end of the second quarter of 2026.  Online revenue for Irwin as a percentage of total revenue has increased from approximately 4% at the time of the acquisition to 24% during the second quarter of 2026. Irwin generated gross margin of 32.8% and contribution as a percentage of revenue of 29.2% during the second quarter of 2026. For the Company overall, revenue increased 65%, gross profit increased 42%, and contribution increased 46% compared to the second quarter of 2025. Gross margin decreased to 37.0% compared to 42.8% during the second quarter last year, primarily attributable to the acquisition of Irwin, which historically operated at a lower gross margin than Legacy FitLife. Contribution as a percentage of revenue decreased to 31.5% compared to 35.4% during the second quarter last year. Management Commentary Dayton Judd, the Company’s Chairman and CEO commented, “The second quarter of 2026 reflected another period of growth for FitLife on a consolidated basis, with total revenue up 65% to $26.5 million, driven by the addition of Irwin Naturals.  Irwin generated $14.1 million of revenue during the quarter, an increase of approximately 10% sequentially, primarily due to the continued growth of Irwin on Amazon, which we launched in mid-October of 2025 and which has grown to an annual revenue run rate of approximately $11 million as of the end of the second quarter. “Legacy FitLife, which includes both MRC and MusclePharm, faced continued headwinds during the quarter, with revenue declining 23% compared to the second quarter of 2025.  The decline was driven by a 19% decrease in online revenue, primarily attributable to MRC, and a 31% decrease in wholesale revenue attributable to lower sales to certain retail partners, primarily GNC. “Irwin continues to generate the majority of its revenue through the wholesale channel, which represented 76% of Irwin’s revenue during the second quarter, with the remaining 24% coming from online sales.  As we continue to grow Irwin’s online presence, including through Amazon, we expect the mix to shift further toward online over time, consistent with the pattern we have seen with our other brands. “Between the closing of the Irwin acquisition and June 30, 2026, we have paid off $8.6 million of debt in addition to paying approximately $2.0 million of transaction-related expenses.  Of the total debt reduction, $4.6 million represents scheduled amortization, and $4.0 million represents voluntary payments to reduce the Company’s outstanding revolver balance.  At the Company’s current 6.5% weighted average interest rate, this $8.6 million debt reduction saves us approximately $0.6 million in annual interest expense.  Going forward, we intend to continue deploying our excess free cash flow to debt reduction, which will reduce interest expense further. “As we have previously discussed, over the past three quarters we have been dealing with a number of challenges.  Some of these challenges—such as consumer weakness and changes in the Amazon algorithms—are outside of our control, whereas others—such as supply chain difficulties and new product development—are within our control. “Although the challenges persist, I am pleased with how our incredible and dedicated employees are responding to them.  In particular, I am encouraged by the sequential growth we experienced in both wholesale and online revenue during the second quarter.  I am confident that we are focused on the right priorities, which I believe will drive continued improvement in the business over the long-term.” Earnings Conference Call The Company will hold an investor conference call on Thursday, August 13, 2026 at 4:30 pm ET.  Investors interested in participating in the live call can dial (833) 492-0064 from the U.S. and provide the conference identification code of 802750.  International participants can dial (973) 528-0163 and provide the same code. About FitLife Brands FitLife Brands is a developer and marketer of innovative and proprietary nutritional supplements and wellness products for health-conscious consumers.  FitLife markets more than 500 different products online and through various retail locations.  FitLife is headquartered in Omaha, Nebraska.  For more information, please visit our website at www.fitlifebrands.com. Forward-Looking Statements Statements in this release that are forward-looking involve known and unknown risks and uncertainties, which may cause the Company's actual results in future periods to be materially different from any future performance that may be suggested in this news release.  Such factors may include, but are not limited to, the ability of the Company to continue to grow revenue, the Company's ability to continue to achieve positive cash flow given the Company's existing and anticipated operating and other costs, and the Company’s ability to service its debt.  Many of these risks and uncertainties are beyond the Company's control.  Reference is made to the discussion of risk factors detailed in the Company's filings with the Securities and Exchange Commission including its reports on Form 10-K and 10-Q.  Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the dates on which they are made. FITLIFE BRANDS, INC.CONDENSED CONSOLIDATED BALANCE SHEETS(In thousands, except per share data) FITLIFE BRANDS, INC. CONDENSED CONSOLIDATED STATEMENTS OF INCOMEFOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2026 AND 2025(In thousands, except per share data)(Unaudited) FITLIFE BRANDS, INC. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWSFOR THE SIX MONTHS ENDED JUNE 30, 2026 AND 2025(In thousands)(Unaudited) Non-GAAP Measures The financial presentation below contains certain financial measures not in accordance with GAAP, defined by the SEC as “non-GAAP financial measures”, including EBITDA and adjusted EBITDA. These measures may be different from non-GAAP financial measures used by other companies. The presentation of this financial information, which is not prepared under any comprehensive set of accounting rules or principles, is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. As presented below, EBITDA excludes interest, foreign exchange gains and losses, income taxes, and depreciation and amortization. Adjusted EBITDA excludes—in addition to interest, foreign exchange gains and losses, taxes, depreciation and amortization—stock-based compensation and merger and acquisition related expense. The Company believes the non-GAAP measures provide useful information to both management and investors by excluding certain expense and other items that may not be indicative of its core operating results and business outlook. The Company believes that the inclusion of non-GAAP measures in the financial presentation below allows investors to compare the Company’s financial results with the Company’s historical financial results and is an important measure of the Company’s comparative financial performance. CONTACT: [email protected]

FitLife Brands Inc. (FTLF) came out with quarterly earnings of $0.2 per share, beating the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.18 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +11.11%. A quarter ago, it was expected that this company would post earnings of $0.14 per share when it actually produced earnings of $0.17, delivering a surprise of +21.43%. Over the last four quarters, the company has surpassed consensus EPS estimates two times. FitLife Brands , which belongs to the Zacks Medical - Products industry, posted revenues of $26.55 million for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 0.19%. This compares to year-ago revenues of $16.13 million. The company has topped consensus revenue estimates just once over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. FitLife Brands shares have lost about 36.9% since the beginning of the year versus the S&P 500's gain of 13.2%. While FitLife Brands has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for FitLife Brands was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.27 on $29.75 million in revenues for the coming quarter and $0.83 on $109.02 million in revenues for the current fiscal year. Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Products is currently in the bottom 37% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. One other stock from the same industry, Medtronic (MDT), is yet to report results for the quarter ended July 2026. The results are expected to be released on September 1. This medical device company is expected to post quarterly earnings of $1.39 per share in its upcoming report, which represents a year-over-year change of +10.3%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. Medtronic's revenues are expected to be $9.48 billion, up 10.5% from the year-ago quarter. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report FitLife Brands Inc. (FTLF) : Free Stock Analysis Report Medtronic PLC (MDT) : Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research

Omeros (OMER) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of a loss of $0.27 per share. This compares to a loss of $0.53 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +107.41%. A quarter ago, it was expected that this drug developer would post a loss of $0.4 per share when it actually produced a loss of $0.24, delivering a surprise of +40%. Over the last four quarters, the company has surpassed consensus EPS estimates four times. Omeros, which belongs to the Zacks Medical - Products industry, posted revenues of $28.53 million for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 130.07%. This compares to zero revenues a year ago. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Omeros shares have lost about 20.8% since the beginning of the year versus the S&P 500's gain of 12.9%. While Omeros has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Omeros was unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #4 (Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is -$0.22 on $19.3 million in revenues for the coming quarter and -$0.13 on $68.8 million in revenues for the current fiscal year. Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Products is currently in the top 44% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. One other stock from the same industry, FitLife Brands Inc. (FTLF), is yet to report results for the quarter ended June 2026. The results are expected to be released on August 13. This company is expected to post quarterly earnings of $0.18 per share in its upcoming report, which represents no change from the year-ago quarter. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. FitLife Brands Inc.'s revenues are expected to be $26.5 million, up 64.3% from the year-ago quarter. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Omeros Corporation (OMER) : Free Stock Analysis Report FitLife Brands Inc. (FTLF) : Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research

FitLife Brands, Inc.'s (NASDAQ:FTLF) recent soft profit numbers didn't appear to worry shareholders, as the stock price showed strength. We think that investors might be looking at some positive factors beyond the earnings numbers. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. To properly understand FitLife Brands' profit results, we need to consider the US$2.8m expense attributed to unusual items. It's never great to see unusual items costing the company profits, but on the upside, things might improve sooner rather than later. We looked at thousands of listed companies and found that unusual items are very often one-off in nature. And that's hardly a surprise given these line items are considered unusual. If FitLife Brands doesn't see those unusual expenses repeat, then all else being equal we'd expect its profit to increase over the coming year. That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates. Unusual items (expenses) detracted from FitLife Brands' earnings over the last year, but we might see an improvement next year. Because of this, we think FitLife Brands' earnings potential is at least as good as it seems, and maybe even better! And on top of that, its earnings per share have grown at an extremely impressive rate over the last three years. Of course, we've only just scratched the surface when it comes to analysing its earnings; one could also consider margins, forecast growth, and return on investment, among other factors. Keep in mind, when it comes to analysing a stock it's worth noting the risks involved. To help with this, we've discovered 4 warning signs (1 shouldn't be ignored!) that you ought to be aware of before buying any shares in FitLife Brands. This note has only looked at a single factor that sheds light on the nature of FitLife Brands' profit. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks with high insider ownership. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Interested in FitLife Brands Inc.? Here are five stocks we like better. Revenue surged 59% year over year to $25.3 million in Q1 2026, largely driven by the Irwin acquisition and a 166% jump in wholesale sales. Online revenue also rose 6% from a year ago. Profitability weakened as gross margin fell to 37.6% from 43.1% and net income slipped to $1.7 million, with higher amortization, interest expense, and lower margins from Irwin pressuring results. The company is still seeing growth opportunities from Irwin’s Amazon rollout and new launches, including Amazon Canada and Kroger placements for MusclePharm, while also continuing to pay down debt. FitLife Brands (NASDAQ:FTLF) reported sharply higher first-quarter 2026 revenue, driven by the acquisition of Irwin, while profitability declined as the company absorbed lower Irwin margins and higher acquisition-related expenses. Chief Executive Officer Dayton Judd said total revenue for the quarter was $25.3 million, up 59% from the same period last year. Wholesale revenue was $14.1 million, or 56% of total revenue, increasing 166% year over year. Online revenue was $11.2 million, or 44% of revenue, up 6% from the first quarter of 2025. → Micron Investors Face a High-Stakes Moment After the Latest Rally Gross margin fell to 37.6% from 43.1% a year earlier, which Judd attributed primarily to the Irwin acquisition. Irwin has historically operated at lower gross margins than Legacy FitLife, he said. However, gross margins improved sequentially for both Legacy FitLife and Irwin from the fourth quarter of 2025 to the first quarter of 2026. Net income was $1.7 million, down from $2.0 million in the prior-year period. Judd said the decline was driven mainly by higher amortization expense and interest expense tied to the Irwin acquisition. Adjusted EBITDA was $3.3 million, down 3% from the first quarter of 2025. → How Bad Could Tesla’s Cybertruck Recall Be for Shares? Irwin generated $12.8 million in first-quarter revenue, with $10.3 million, or 80%, coming from wholesale customers and 20% from online sales. Irwin’s gross margin was 34.0%, and contribution as a percentage of revenue was 31.3%. Judd said FitLife began selling Irwin products on Amazon in mid-October and saw the business scale throughout the fourth quarter. Irwin Amazon revenue reached almost $500,000 in December 2025, approximately $800,000 in March 2026 and approximately $900,000 in April 2026. He said the account continued to grow sequentially in May month to date, though the pace of growth had slowed. → Reading the Stripes: Is The Industrial Recession Over? FitLife said Irwin’s organic revenue declined approximately 13% year over year after adjusting for the loss of Costco U.S. and Rite Aid as customers before the acquisition and excluding CBD products because the company decided to exit the CBD market. Judd estimated that $1 million to $1.5 million, or more than half of the decline, was tied to previously discussed out-of-stock issues. Judd said the company expects Irwin to have additional growth opportunities on Amazon as it resolves out-of-stock situations, sets up listings for products not yet available on the platform and launches Canadian products on Amazon Canada later in the second quarter. He also said Irwin’s Amazon subscriber count increased from roughly 500 at the beginning of the first quarter to approximately 3,600 at quarter-end and more than 5,700 at the time of the call. Legacy FitLife revenue was $12.5 million, with 70% from online sales and 30% from wholesale customers. Judd said wholesale revenue declined 28% year over year and online revenue fell 18%, producing a 22% decline in total revenue. The declines were primarily tied to lower online revenue for MRC and lower wholesale revenue from GNC. Judd said the year-over-year wholesale comparison was particularly difficult because the first quarter of 2025 included restocking of GNC distribution centers following the resolution of a previously disclosed commercial dispute that had caused FitLife to stop shipments to GNC. Legacy FitLife gross margin declined to 41.2% from 43.1% a year earlier, but improved from 40.7% in the fourth quarter of 2025. Contribution declined 27% to $4.3 million, and contribution as a percentage of revenue fell to 34.1% from 36.5%. Sequentially, contribution was approximately flat, while contribution margin improved from 32.5% in the fourth quarter. FitLife made a scheduled amortization payment of approximately $1.5 million during the quarter, reducing its term loan balance to $37.6 million. The company also paid down an additional $1.4 million on its revolving line of credit, bringing that balance to $4.2 million. Judd said FitLife intends to continue using excess free cash flow to reduce indebtedness. In response to a question from Ryan Meyers of Lake Street Capital Markets, Judd said revenue improved sequentially through the quarter. January was “kind of tough,” February was similar to January but stronger on a revenue-per-day basis, and March was above 9% in terms of revenue, he said. April revenue was higher than January and February but lower than March, though Judd said April was the company’s highest sales order month of the year. He noted that shipment timing affected revenue recognition. Asked about Irwin’s Amazon potential, Judd said he did not see a reason the business would not reach at least $1 million per month. He cited roughly 20 Irwin products not yet set up for Amazon sales, out-of-stock products that have limited sales on the platform, the opening of Amazon Canada and increased advertising as potential tailwinds. Sean McGowan of Roth Capital asked about MusclePharm. Judd said MusclePharm revenue was down “by choice,” as FitLife opted not to sell to some large international protein buyers at very low margins. He said online performance had improved from earlier double-digit declines to being down only slightly, and he expects MusclePharm margins to improve because the company is selling less to lower-margin international customers. Judd also said FitLife is working to adapt to changes in Amazon’s marketplace dynamics by shifting more marketing dollars off Amazon and toward Google Ads, Meta Ads and TikTok. He said the company was “absolutely not declaring victory” but was seeing some positive trends. FitLife also announced the launch of two MusclePharm liquid L-carnitine SKUs in several hundred Kroger stores nationwide beginning in June. In response to Samir Patel of Askeladden Capital, Judd said the products will be sold in roughly 700 to 800 stores across multiple Kroger banners, including Kroger, Fred Meyer and Smith’s. He said the company plans marketing support including connected TV advertising, possible direct mail and neck-band coupons to encourage trial. Judd said the Kroger opportunity began before the Irwin acquisition, though FitLife expects synergies from Irwin’s existing relationships and broker network. He said the initiative has been a major focus for the company’s new chief marketing officer and consolidated marketing team. FitLife Brands, Inc provides nutritional supplements for health-conscious consumers in the United States and internationally. The company provides weight loss, sports nutrition, and general health products; sports nutrition products; weight loss and sports nutrition products; sports nutrition and general wellness formulations with an emphasis on natural, vegan, and organic ingredients; and male health and weight loss products, as well as other diet, health, and sports nutrition supplements and related products; and value-oriented sports nutrition and weight loss products. This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. The article "FitLife Brands Q1 Earnings Call Highlights" was originally published by MarketBeat. View MarketBeat's top stocks for May 2026.

This article first appeared on GuruFocus. Release Date: May 14, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. FitLife Brands Inc (NASDAQ:FTLF) reported a 59% increase in total revenue for Q1 2026, driven primarily by the acquisition of Erwin. Wholesale revenue saw a significant increase of 166% compared to the first quarter of 2025. Online revenue increased by 6% compared to the first quarter of 2025. Sequential improvement in gross margins for both Legacy FitLife and Erwin, with expectations for further margin improvements. Erwin's Amazon business showed strong growth, with revenue reaching approximately $900,000 in April 2026. Gross margin declined from 43.1% in Q1 2025 to 37.6% in Q1 2026, primarily due to the acquisition of Erwin. Net income decreased to $1.7 million from $2.0 million in Q1 2025, impacted by higher amortization and interest expenses. Legacy FitLife experienced a 22% decrease in total revenue, with declines in both wholesale and online sales. Organic revenue for Erwin declined approximately 13% year-over-year, partly due to out-of-stock situations. Adjusted EBITDA decreased by 3% compared to the first quarter of 2025. Warning! GuruFocus has detected 6 Warning Signs with FTLF. Is FTLF fairly valued? Test your thesis with our free DCF calculator. Q: Can you discuss the sequential improvement in monthly revenue throughout the first quarter and into April and May? A: Dayton Judd, CEO: January and February were challenging, with revenue in the low eights range. March saw an increase to above nine. April was higher than January and February but slightly lower than March. April was our highest sales order month this year, with many shipments at the end of the month, affecting revenue recognition. Overall, April was strong when normalized for shipments. Q: What is the potential upside for the Irwin business before reaching a steady state revenue rate? A: Dayton Judd, CEO: It's difficult to pinpoint, but we anticipate reaching at least a million a month. Several products are still not set up on Amazon, and resolving out-of-stock issues will provide additional tailwinds. We are also expanding into Canada and increasing advertising efforts, which should contribute to growth. Q: How is Muscle Farm performing in terms of revenue and margins? A: Dayton Judd, CEO: Revenue is down by choice, as we opted not to sell to margin-aggressive international players. Online sales are doing well, with some momentum returning. Margins are expected to improve as we focus on higher-margin online sales and avoid low-margin international accounts. Q: Can you provide an update on the dating initiative with the bottles and its impact on shrink? A: Dayton Judd, CEO: We have received several products with three-year dating and have more in production. We've reduced obsolescence significantly and expect margins to improve as we write off less inventory. The reserve for obsolescence is now much lower, indicating progress. Q: What are the details of the new Muscle Farm placement in Kroger stores, and how does it compare to previous initiatives like the Vitamin Shoppe pilot? A: Dayton Judd, CEO: We are launching two flavors of liquid L-carnitine in 700-800 Kroger stores nationwide. This product type is familiar to us and has performed well in other channels. We are employing targeted marketing strategies, including CTV ads and neckband coupons, to ensure success. This initiative began before acquiring Erwin, but the Erwin team has provided synergies in the process. For the complete transcript of the earnings call, please refer to the full earnings call transcript.